NeuroPace said today that its epilepsy neuromodulation technology will be studied for its efficacy in treating binge-eating disorder in certain patients. The Mountain View, Calif.-based company’s RNS system is a closed-loop technology approved to treat adults with medically refractory focal onset epilepsy. The clinical trial will examine whether neuromodulation could help patients with a body […]
Inspire Medical scores reimbursement win from UnitedHealth
Inspire Medical Systems (NYSE:INSP) logged another reimbursement win, this time with the nation’s largest private insurer, UnitedHealth. Minneapolis-based Inspire makes an eponymous device designed to treat obstructive sleep apnea using hypoglossal nerve stimulation. UnitedHealth has about 41 million lives under coverage, Inspire said. “We are very pleased to receive this positive coverage decision from UnitedHealthcare. […]
Boston Scientific gets in on $75m round for Saluda Medical
A day after taking out a loan from Medtronic (NYSE:MDT), Saluda Medical brought in $75 million with an equity round joined by Boston Scientific (NYSE:BSX). Australia- and Bloomington, Minn.-based Saluda said Redmile Group and “one other financial institution” participated in the round. Yesterday the company took out a four-year term loan from Medtronic for an unspecified amount, marking […]
DW Healthcare Partners acquires Cefaly
DW Healthcare Partners announced this week that it acquired Cefaly Technology for an undisclosed amount. “We are excited to partner with DWHP and are very thankful to Stout for introducing us to DWHP and initiating and driving the completion of this very complex and important transaction,” co-founder & CEO Pierre Rigaux said in a press […]
Saluda Medical wins another investment from Medtronic
Saluda Medical said today that it took out a four-year term loan from Medtronic (NYSE:MDT) for an unspecified amount, marking the medtech titan’s third investment in the spinal cord stimulation device maker. In May 2017, Australia- and Bloomington, Minn.-based Saluda raised nearly $40 million for the Evoke closed-loop neuromodulation device it’s developing to treat axial […]
Axonics wins FDA nod for MR-safe neurostim device in trial
Axonics Modulation Technologies (NSDQ:AXNX) said today that the FDA approved the use of full-body MRI for clinical trial participants implanted with the company’s sacral neuromodulation device. The Irvine, Calif.-based company submitted a supplement to the FDA regarding the use of full-body MRIs in its Artisan-SNM 129-patient pivotal trial. The FDA, which is evaluating Axonics’ device via […]
CyMedica launches another trial of muscle-strengthening device
CyMedica Orthopedics said it has launched a clinical trial to evaluate the effectiveness of its E-vive muscle-strengthening device and patient engagement system in knee osteoarthritis patients. Researchers will combine the data generated by the E-vive neuromuscular electrical stimulation device with the activity and health data collected by commercially available wearable smartwatch devices to determine the effect […]
Checkpoint Surgical touts nerve monitor study results
Checkpoint Surgical today announced the results of a study that called its handheld nerve monitor a safe and reliable alternative to existing technology for neural monitoring during surgery. The retrospective study compared the use of the Cleveland, Ohio-based company’s Checkpoint nerve stimulator/locator to Medtronic’s nerve integrity monitor for vagal, recurrent and superior laryngeal nerve monitoring […]
Abbott inks neuroscience research deal with NIH
Abbott (NYSE:ABT) said today that it inked a partnership deal with the National Institutes of Health to support the Brain Research through Advancing Innovative Neurotechnologies, or BRAIN initiative. The NIH’s BRAIN initiative aims to accelerate neuroscience research and advancements, Chicago-area based Abbott said. Through the partnership, Abbott will provide its neuromodulation tech, including directional deep brain […]
Omron joins $35m Theranica Series B
Theranica said today that Omron‘s (TYO:6645) venture arm joined a $35 million Series B financing round to support its remote neuromodulation technology. Israel-based Theranica is developing the Nerivio Migra neurostimulation patch intended to treat migraine headache, which is currently under FDA review. Funding in the round, which was initially announced in March, was led by […]
HRS 2019: Parasym ear stim device shows promise in AFib
Noninvasive neurostimulation of the ear shows promise when it comes to treating atrial fibrillation, according to clinical study results presented today at the Heart Rhythm Society’s annual scientific sessions, held in San Francisco. University of Oklahoma researchers over a six-month period studied the effects of London-based Parasym‘s noninvasive neurostimulation device on roughly 50 paroxysmal AFib […]
- 1
- 2
- 3
- …
- 53
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube